Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Nektar Therapeutics logo

Nektar Therapeutics

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 81 M  90-day average vol: 1,672,419

Previous close: 0.49  Open: 0.495  Bid: 0.5002  Ask: 0.525
52 week range    
PFE / 
MRK / 
BAX / 
JNJ / 
AZN / 
NVS / 
Last updated: Monday 4th December 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)



0.0347129 B23.4223.53



0.012943 B35.986.87


0 B-10.30.3736


0.0247450 B22.1171.06


0.0356207 B28.877.58



0.0302298 B15.153.21


0.01970 B1912.16

NKTR Income Statement

Basic EPS from continuing operations-2.52-2.49-2.86
Basic EPS total-0.41-0.35-0.4-0.28-0.624.02-2.52-2.49-2.86-1.97
Basic weighted shares outstanding116 M127 M132 M140 M156 M170 M175 M179 M183 M187 M
Cost of sales-39 M-29 M-34 M-30 M-31 M-24 M21 M19 M25 M-22 M
Depreciation-13 M-12 M-11 M-13 M-13 M-9 M11 M13 M13 M-12 M
DepreciationAndAmortization-13 M-12 M-11 M-13 M-13 M-9 M11 M13 M13 M-12 M
Diluted EPS total-1.4-0.42-0.61-1.1-0.623.78-2.52-2.49-2.86-1.97
Diluted normalized net income/share-2.52-2.49-2.86
Diluted weighted shares outstanding116 M128 M133 M140 M156 M180 M175 M179 M183 M187 M
GainOnSaleOfPPE3 M
GainOnSaleOfSecurity3 M22 M43 M79000.0-533000.0
GeneralAndAdministrativeExpense41 M41 M43 M44 M52 M81 M99 M105 M123 M92 M
Gross operating profit110 M172 M197 M135 M261 M1,169 M93 M133 M77 M-66 M
ImpairmentOfCapitalAssets-66 M
Income before tax-160 M-54 M-81 M-153 M-96 M683 M-440 M-444 M-523 M-365 M
Income restructuring and M&A-136 M
Income taxes2 M-512000.0506000.0876000.0616000.01 M613000.0493000.0557000.03 M
Interest income-22 M-21 M-21 M-20 M-19 M-21 M5 M
InterestExpenseNonOperating18 M18 M18 M22 M22 M22 M21 M7 M
InterestExpenseOperating-17 M-20 M-21 M-20 M
MiscOtherSpecialCharges1 M814000.0-12 M2 M5 M38 M21 M-12 M-69 M7 M
Net income from total operations-162 M-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M
NetIncomeCommonStockholders-162 M-54 M-81 M-154 M-97 M681 M-441 M-354 M-524 M-368 M
NetIncomeContinuousOperations-162 M-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M
NetNonOperatingInterestIncomeExpense-41 M-39 M-39 M-42 M-41 M-43 M-21 M-7 M5 M
Normalized income-405 M
Operating income-120 M-16 M-29 M-113 M-60 M688 M-440 M-425 M-446 M-376 M
Operating income before depreciation (EBITDA)-127 M-41 M-70 M-135 M-79 M715 M-406 M-419 M-502 M-354 M
OperatingExpense231 M189 M226 M248 M321 M481 M533 M513 M523 M311 M
Other income net-1 M-814000.012 M-2 M-5 M-38 M-21 M12 M77 M-7 M
OtherGandA41 M41 M43 M44 M52 M81 M99 M105 M123 M92 M
OtherOperatingExpenses-8 M-50 M-3 M-2 M-17 M
OtherWriteDown-2 M
RentAndLandingFees41 M41 M43 M44 M52 M81 M92 M
Research & development expense190 M148 M183 M204 M268 M400 M435 M409 M400 M218 M
ResearchExpense190 M148 M183 M204 M268 M400 M435 M409 M400 M218 M
RestructringAndMnAIncome-136 M
SalariesAndWages-18 M-17 M-20 M-26 M-37 M-88 M-57 M
Selling Gen & administrative expense41 M41 M43 M44 M52 M81 M99 M105 M123 M92 M
Special income/charges202 M
Total Income available for interest expense (EBIT)-141 M-54 M-83 M-151 M-94 M704 M-419 M-437 M-523 M-365 M
Total common shares outstanding127 M131 M136 M154 M161 M174 M178 M182 M186 M189 M
Total net income-162 M-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M
Total ordinary shares191 M191 M191 M191 M191 M191 M191 M191 M191 M191 M
Total revenues149 M201 M231 M165 M308 M1,193 M115 M153 M102 M92 M
TotalExpenses192 M160 M192 M218 M290 M457 M555 M533 M548 M289 M
TotalRevenue45 M25 M40 M55 M308 M1,193 M115 M153 M102 M92 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today